Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
La Revue Du Praticien|August 5, 2008
[Adrenal hypertension]Pierre-François Plouin, Laurence Amar, Charlotte Lepoutre-Lussey
Blood Pressure|December 17, 2009
Cardiovascular risk factors in hypertensive patients born in Northern Africa and living in FranceCharlotte Lepoutre-Lussey, Pierre-François Plouin, Olivier Steichen
Current Opinion in Endocrinology, Diabetes, and Obesity|August 15, 2014
Postoperative radioactive iodine administration for differentiated thyroid cancer patientsCharlotte Lepoutre-Lussey, Désirée Deandreis, Sophie Leboulleux, et al.
European Journal of Endocrinology|March 25, 2014
Post-operative neck ultrasound and risk stratification in differentiated thyroid cancer patients with initial lymph node involvementCharlotte Lepoutre-Lussey, Dina Maddah, Jean-Louis Golmard, et al.
European Journal of Endocrinology|November 4, 2011
Primary adrenal angiosarcoma and functioning adrenocortical adenoma: an exceptional combined tumorCharlotte Lepoutre-Lussey, Audrey Rousseau, Abir Al Ghuzlan, et al.
The Oncologist|December 18, 2015
Outcomes and Prognostic Factors in Radioiodine Refractory Differentiated Thyroid CarcinomasJohanna Wassermann, Marie-Odile Bernier, Jean-Philippe Spano, et al.
European Journal of Endocrinology|October 7, 2010
A novel TMEM127 mutation in a patient with familial bilateral pheochromocytomaNelly Burnichon, Charlotte Lepoutre-Lussey, Julien Laffaire, et al.
Oral Oncology|January 18, 2015
(18)F-fluorodeoxyglucose positron emission tomography to assess response after radiation therapy in anaplastic thyroid cancerAntonin Levy, Sophie Leboulleux, Charlotte Lepoutre-Lussey, et al.
Thyroid : Official Journal of the American Thyroid Association|January 31, 2015
Postoperative fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography: an important imaging modality in patients with aggressive histology of differentiated thyroid cancerCamila Nascimento, Isabelle Borget, Abir Al Ghuzlan, et al.
The Journal of Clinical Endocrinology and Metabolism|November 19, 2014
SDHD immunohistochemistry: a new tool to validate SDHx mutations in pheochromocytoma/paragangliomaMélanie Menara, Lindsey Oudijk, Cécile Badoual, et al.
Pageof 2